We have applied convolution methods to account for some of the effects of respiratory induced motion in clinical treatment planning of the lung. The 3-D displacement of the GTV center-of-mass ͑COM͒ as determined from breath-hold exhale and inhale CT scans was used to approximate the breathing induced motion. The time-course of the GTV-COM was estimated using a probability distribution function ͑PDF͒ previously derived from diaphragmatic motion ͓Med. Phys. 26, 715-720 ͑1990͔͒ but also used by others for treatment planning in the lung ͓Int. J. Radiat. Oncol., Biol., Phys. 53, 822-834 ͑2002͒; Med. Phys. 30, 1086 -1095 ͑2003͔͒. We have implemented fluence and dose convolution methods within a Monte Carlo based dose calculation system with the intent of comparing these approaches for planning in the lung. All treatment plans in this study have been calculated with Monte Carlo using the breath-hold exhale CT data sets. An analysis of treatment plans for 3 patients showed substantial differences ͑hot and cold spots consistently greater than Ϯ15%) between the motion convolved and static treatment plans. As fluence convolution accounts for the spatial variance of the dose distribution in the presence of tissue inhomogeneities, the doses were approximately 5% greater than those calculated with dose convolution in the vicinity of the lung. DVH differences between the static, fluence and dose convolved distributions for the CTV were relatively small, however, larger differences were observed for the PTV. An investigation of the effect of the breathing PDF asymmetry on the motion convolved dose distributions showed that reducing the asymmetry resulted in increased hot and cold spots in the motion convolved distributions relative to the static cases. In particular, changing from an asymmetric breathing function to one that is symmetric results in an increase in the hot/cold spots of Ϯ15% relative to the static plan. This increase is not unexpected considering that the target spends relatively more time at inhale as the asymmetry decreases ͑note that the treatment plans were generated using the exhale CT scans͒.
I. INTRODUCTION
Conformal radiotherapy treatment planning is typically based on a single CT scan, which represents one instance of the patient anatomy. However, in order to more accurately estimate the dose to the tumor, it is important in such sites as the lung and liver, that the respiratory-induced motion be accounted for within the dose calculations. Differences that result between the planned dose distributions in the static and motion-compensated cases can be clinically significant ͑par-ticularly in the context of dose escalation͒, as pointed out in a recent study by Rosu et al., 4 involving treatment planning of tumors in the liver. Several investigators have proposed methods to account for organ motion in treatment planning. [1] [2] [3] [4] [5] [6] [7] 11 One traditional approach has been to convolve the static dose distributions with functions that approximate the breathing. 1, 7 In particular, the application of this approach for treatment planning in the liver by Lujan et al. 1 has shown that applying a single convolution to the static dose distribution is sufficient to predict the dose distribution for the given fractionated treatment; intra-fraction effects were found to average out over the course of many fractions. Potential limitations 1, 8, 9 of the dose convolution approach include the following assumptions: ͑a͒ the dose is spatially invariant for small changes in the geometry ͑i.e., the convolution of the dose is conducted in an assumed homogeneous medium͒, ͑b͒ the motion is based on a rigid body approximation, and ͑c͒ the method applies over an ''infinite'' number of fractions.
More recently, the use of Monte Carlo based dose calculation algorithms have facilitated a new approach to account for random setup errors 10 and breathing-induced motion.
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This approach termed ''fluence convolution'' is performed by convolving the particle fluence with the appropriate motionrelated functions. Fluence convolution is based on the reciprocity principle of motion between the incident fluence and the patient-convolving the fluence with the patient anatomy held fixed is theoretically equivalent to shifting patient anatomy with the fluence being stationary. 10 The benefit of fluence convolution over dose convolution is that it is based on a direct simulation approach, that is, the dose is recalcu-lated at each instance of the translated fluence. The calculated dose distribution is therefore not spatially invariant as in the case of dose convolution. However, as with dose convolution, fluence convolution is also limited by the rigid body approximation and by the fact that dose fraction effects are ignored.
The intent of this study was to apply convolution methods ͑both fluence and dose convolution͒ to account for some of the effects of respiratory-induced motion of the gross tumor volume ͑GTV͒ in treatment planning for lesions located within the lung. Motion of the GTV has been estimated by evaluating the excursion of the center-of-mass ͑COM͒ between normal breath-hold exhale and inhale CT scans. We compare calculations using the convolution implementations with those from the static ͑no motion case͒ for the CTV and PTV. In all cases, treatment plans have been generated using a Monte Carlo based dose calculation algorithm.
II. METHODS AND MATERIALS

A. Image acquisition and target center-of-mass motion
As part of a new CT imaging study protocol ͑at our institution͒ for patients with lung cancer, CT data are acquired in the normal breath-hold inhale and exhale positions, as well as at an arbitrary free-breathing state. In this study, the breath-hold inhale and exhale CT scans were used to estimate the center-of-mass ͑COM͒ motion of the gross tumor volume ͑GTV͒. The GTV was delineated by the physician on the inhale and exhale CT data sets. The treatment planning volumes: GTV, clinical target volume ͑CTV͒, and planning target volume ͑PTV͒ are those recommended by the ICRU Report No. 50. 12 During standard ͑static͒ treatment planning, the GTV is outlined on the breath-hold exhale CT scan; the CTV is formed by a uniform, 0.5 cm expansion of the GTV and the PTV includes a further 1.0 cm uniform expansion for setup uncertainties and breathing-induced motion of the tumor.
The general methodology for assessing target motion was to calculate the displacement of the GTV-COM between inhale and exhale extents of breathing. This was accomplished by calculating the COM coordinates on the inhale and exhale CT scans using the equation
where x i , y i , z i represent the coordinates, and m i the mass of voxel i. Voxels for the COM calculation constitute the 3-D generated GTV volume within the treatment planning system ͑UMPlan͒. The displacement vector of the GTV-COM (R com ) between inhale and exhale is then given by the equation
where the subscripts I represent the COM coordinates in the inhale position and the subscripts E represent those in the exhale position. 15 -this system has been integrated into our in-house treatment planning system, UMPlan ͑University of Michigan, Ann Arbor, MI͒. The source model was reconstructed from phase space calculations of the treatment head components of a Varian 21EX linear accelerator ͑Varian Associates, Palo Alto, CA͒ generated with the BEAMnrc Monte Carlo code ͑CNRC, Ottawa, CN͒. The source particle's position and energy are sampled from the respective fluence and bremsstrahlung distributions, and the direction is calculated assuming that the particle emerged from a point. Arbitrary field shapes are simulated by multiplying the uncollimated fluence map by a matrix describing the MLC configuration. In order to account for the finite width of the target and leaf edge penumbral effects, the shaped-beam fluence map is convolved with a Gaussian kernel as described previously. 13 
Fluence convolution and motion of the COM
The general fluence convolution method involves convolving the static beam fluence with a function that describes the respiratory-induced motion. In this paper we use the following notation: ⌽ static represents the MLC-shaped field static fluence distribution, F motion the function describing the breathing motion, and ⌽ motion the convolved fluence map which incorporates the motion. For a point, r, that undergoes the motion, we have
F motion , is the probability distribution function ͑PDF͒ derived from the position-time function for tumor motion, and may be estimated by observing the breathing-induced motion under fluoroscopy as described previously by other investigators. 2, 3, 16, 17 To estimate the GTV-COM position as a function of time we use a function originally proposed by Lujan et al. 1 to account for breathing-induced ͑superior-inferior͒ motion in treatment planning of lesions in the liver. This function is given by
where z 0 is the position at exhale, a the amplitude of the motion, the period of the breathing cycle, n a parameter that determines the degree of asymmetry of the model ͑i.e., how much the respiratory cycle is biased toward exhale͒, and the starting phase of the breathing cycle. 1 In this study we assume that the GTV-COM moves according to the function in Eq. ͑4͒ along a trajectory R com (x,y,z). Lujan et al. 1 show further that Eq. ͑4͒ can be recast to yield a probability that a point lies between z and zϩdz, which is equal to the fraction of the total time that a point spends in the interval between t and tϩdt. The resulting PDF ͑labeled F motion ), upon replacing z with r is as follows:
where R 0 represents the position of the GTV-COM at exhale, and r the arbitrary position along the trajectory R com (x,y,z). The assumption here is that the 3-D vector R com (x,y,z) follows the same time course as the 1-D displacement, z. All other parameters are the same as those defined in Eq. ͑4͒ above.
In this study, we have not monitored the tumor location as a function of time but have assumed that the tumor has a rectilinear trajectory following the time course described in Eq. ͑4͒. Although Eq. ͑4͒ may have limited applicability to individual patients, it has been found to provide a reasonable fit to population-based lung tumor motion. 2, 3 In particular, Seppenwoolde et al., 2 who fluoroscopically imaged implanted markers for 20 lung cancer patients, found that Eq. ͑4͒ provided a reasonable fit of the breathing-induced tumor motion in these patients. Seppenwoolde et al. 2 classified tumors according to those in the upper, middle and lower lobes of the lung and found that the degree of asymmetry of the breathing function ͑determined by the parameter n in Eqs. ͑4͒, ͑5͒͒ generally varied between nϭ1 and 3. Recently Engelsman et al. 3 conducted a theoretical treatment planning study in which they assume that the lung tumor motion is described by Eq. ͑4͒ with a value of nϭ3. We include an analysis of the influence of the asymmetry of the breathing function on the dose distributions by conducting fluence convolved calculations with values of n varying from 1 to 3 ͑see Figs. 1-3͒.
In the Monte Carlo implementation, F motion is divided into m probability bins, from the position at exhale (R 0 ) to the position at inhale (R 0 Ϫa). The first mϪ1 bins are equally spaced-we use 3 mm bins to match the dose scoring voxel size-with the last bin being of arbitrary width in order to sample the correct R com amplitude. For example, if the amplitude of R com is 1.4 cm the first 4 bins would have width 3 mm, and the last bin would have width 2 mm. The position (x, y at a fixed z location͒ and energy for each particle starting from the virtual source is determined by first sampling ⌽ static . The source particle's incident direction is determined from the position coordinates assuming that the particle originated from a point, 13 i.e., uϭx/rЈ, vϭy/rЈ, w ϭz/rЈ, where rЈϭ(x 2 ϩy 2 ϩz 2 ) 0.5
. To account for the GTV-COM motion in the R com direction, F motion is sampled to determine the positional translation, ␦R com . The translations ␦x, ␦y, and ␦z are determined according to the relations
where
The following relation may then be used to describe the coordinate transformation from the static fluence distribution ⌽ static , in the unprimed coordinates, to the motion convolved fluence, ⌽ motion , in the primed coordinates: 
Dose convolution
The influence of respiratory motion on the dose distribution was also evaluated using a dose convolution method, 1 performed by convolving the static dose distribution, D static , ͑calculated using ⌽ static ) with the function, F motion , described above. The dose at a point r, that undergoes the motion, is calculated as follows:
This implementation has been modified from the original version of Lujan et al. 1 who only considered motion in the z-axis. F motion here is cast in the form of a 3-D discrete matrix and the convolution with D static is conducted along the vector R com (x,y,z). As in the case with fluence convolution, the amplitude ͉R com ͉ is divided into 3 mm equally spaced bins with the exception of the last bin which is of variable width.
C. Monte Carlo treatment planning
Treatment planning for three patients with tumors at different locations in the lung was conducted using the DPM Monte Carlo code within the framework of the UMPlan system. For all patients, static and fluence convolved planning was performed independently using the breath-hold exhale CT data sets. Dose convolved plans were generated by applying a post-processing convolution to the static beam dose distribution. The typical treatment plan beam configuration consisted of conformal 6/15 MV anterior, lateral and oblique fields, combined with segmental fields ͑directed from the same angles͒ to produce a dose distribution of 100Ϯ5% within the PTV. All plans were normalized to 100% at the isocenter.
DPM calculations were performed using a voxel size of 3ϫ3ϫ3 mm 3 , a 2 mm step size, and low energy electron and photon cut-off values of 200 and 50 keV, respectively. For each treatment plan, approximately 1 billion histories per field were simulated, resulting in 1 statistics of roughly less than 1.5% in the calculated dose, if we include the 1% latent uncertainty in the reconstructed fluence ͑from the virtual source͒. The time required for these simulations was approximately 8 hours per 1 billion particles, running on a single 1 GHz, VMS-based, Alpha processor. Figure 1 shows plots of the probability as a function of GTV-COM position (r), as described by Eq. ͑5͒, for different values of n (nϭ1,2,3). The probability of finding the GTV-COM at exhale increases as the value of n increases indicating that the breathing PDF becomes asymmetrically weighted toward the exhale position with increasing n. Figure 2 shows difference maps between the fluence convolved and static dose distributions ͑i.e., fluence-static͒ in the coronal view for patient A. The fluence convolved calculations were performed by sampling breathing PDF's ͓Eq. ͑5͔͒ for two different values of n (nϭ1,3). An increase in the dose differences ͑fluence-static͒ is noted as the value of n decreases; the maximum differences are approximately Ϯ20% for nϭ3,Ϯ30% for nϭ2 and Ϯ40% for nϭ1. This trend is expected if we consider that the static treatment plans were performed using the exhale CT scan-as n decreases the breathing function becomes more symmetric with the result that a greater fraction of time is spent at the inhale position relative to larger values of n. Figure 3 illustrates the dose-volume-histogram ͑DVH͒ for the static and fluence convolved plans ͑with nϭ1 -3), shown specifically for the PTV ͓Fig. 3͑a͔͒ and the CTV ͓Fig. 3͑b͔͒. We see that the gradient of the PTV DVH is reduced as the value of n decreases-the DVH shoulder is degraded while the high dose region is increased showing the influence of the cold and hot spots which worsen as n decreases. A similar trend was found for the CTV DVH's ͓Fig. 3͑b͔͒, however, the differences were less significant in comparison to the PTV as a consequence of proper PTV design in the static plan.
III. RESULTS AND DISCUSSION
A. Influence of the breathing function asymmetry
B. Treatment planning analysis "static vs motion convolved planning…
Amplitudes for the exhale/inhale excursion of the GTV-COM are presented in Table I for the 3 patients planned in this study. For patient A, the GTV-COM is found to move 1.3 cm in the superior direction and 0.6 cm anteriorly. The largest motion for patient B was observed in the inferior direction (ϳ1 cm) and for patient C this occurred in the anterior direction (ϳ1 cm).
Illustrated in Fig. 4 are the dose difference maps in the coronal view ͑for patient A͒ for ͑a͒ dose convolution (n ϭ3)-static, and ͑b͒ fluence (nϭ3)-dose (nϭ3). Note that the difference map for the fluence convolution (nϭ3) and static dose distributions is presented in Fig. 2͑a͒ . In the difference maps shown in Figs. 2͑a͒ and 4͑a͒, hot and cold spots are located superiorly and inferiorly, respectively. This is because the static treatment plans were conducted in the exhale position and that the GTV-COM for this patient moved predominantly in the superior direction during inhale; that is, relative to the exhale position, the superior region of the target moves out of the beam during inhale while the inferior edge moves into the beam resulting in the respective cold and hot spots. From the difference maps in Figs. 2͑a͒ and 4͑a͒ we also see that the fluence and dose convolved distributions are generally in good qualitative agreement, however, a more detailed evaluation reveals some differences. In the fluence convolved case ͓Fig. 2͑a͔͒ the maximum and minimum differences are ϩ25% and Ϫ20%, respectively-these differences are not symmetric as there is preferentially more dose deposited in the lung due to the increased lateral electron transport in this region. This illustrates that fluence convolution is able to account for the variation in tissue densities surrounding the target. For the dose convolution situation ͓Fig. 4͑a͔͒ the maximum and minimum differences are symmetric (Ϯ25%) as the convolution is spatially invariant, showing that this method does not account for the influence of inhomogeneous tissues on the dose distribution. The differences between fluence and dose convolution are further demonstrated in Fig. 4͑b͒ ͑fluence-dose convolution͒ where we find positive differences up to 7%. Figure 5 illustrates the DVH's for patient A for ͑a͒ the PTV ͑differential͒ and ͑b͒ the CTV ͑integral͒. Plots are shown for the static and the fluence and dose convolved dose distributions. It is clear that there is a systematic shift toward higher doses for the fluence convolved differential DVH ͓Fig. 5͑a͔͒ relative to the static and dose convolved cases. The reason for this is that, while hot and cold spots are found at the inferior and superior edges of the PTV, respectively, the hot spots are greater and tend to dominate the overall dose to the PTV. For the dose convolution plan the PTV DVH more closely agrees with that of the static case because the hot and cold spots tend to offset each other. CTV differences between the static, fluence and dose convolved plans are similar in trend to that of the PTV but are smaller in magnitude as observed in Fig. 5͑b͒ . Dose difference maps and DVH's for the motion convolved and static beam calculations for patient B are illustrated in Fig. 6 . The beam arrangement for patient B was similar to that of patient A, however, patient B differed with respect to ͑a͒ the location of the hot and cold spots, and ͑b͒ the location of the tumor. Figure 6͑a͒ illustrates a difference 
the absolute differences between the exhale and inhale positions. The direction of motion along each of the patient axes is provided in parentheses. Also shown are the magnitudes of the R com (x,y,z) vector. Positive movements from exhale to inhale are directed along the patient's: left (ϩx), posterior (ϩy), and superior (ϩz). map between the fluence convolved (nϭ3) and static doses in the sagittal view, where the maximum and minimum dose differences are ϩ28% and Ϫ24%, respectively. These differences are larger than those for patient A because the GTV for patient B is surrounded by much more lung tissue. In contrast to patient A, the hot and cold spots in the difference maps for patient B are located superiorly and inferiorly respectively; in the case of patient B, the GTV-COM moves inferiorly during inhale resulting in a cold spot as the inferior edge moves out of the beam, and a hot spot as the superior edge moves into the beam. An analysis of the dose difference map between the fluence and dose convolved distributions showed maximum differences of ϩ5%. Much like the case of patient A, these differences were predominantly positive and resulted from the shift invariance assumption of dose convolution in the presence of inhomogeneous tissues. DVH's for the PTV for patient B are shown in Fig. 6͑b͒ . A subtle dose reduction at the shoulder of the PTV DVH is noted for the motion ͑fluence and dose͒ convolved plans, however, the differences relative to the static case are fairly insignificant. A likely reason for this is that the Monte Carlo static dose calculation is expected to correctly account for the spread of dose from the target into the surrounding lung; convolving the static dose in this region either by fluence or dose convolution is therefore unlikely to cause a substantial variance in the dose distribution relative to the static case. This effect has been described previously. 11 Similarly, differences in the CTV DVH's between static and motion convolved plans were minimal suggesting that the PTV was relatively well designed, i.e., the dose to the CTV was not compromised in the presence of motion.
Patient
Presented in Fig. 7͑a͒ is the fluence-static dose difference display for the 7-field conformal beam arrangement for patient C. In this case, the largest differences (ϩ14% and Ϫ11%) occur in the AP direction-this is expected because the GTV-COM moves predominantly in the anterior direction ͑see Table I͒ . The difference map between the fluence and dose convolved plans is shown in Fig. 7͑b͒ . We see differences of ϩ4% in the vicinity of the PTV, however, much larger differences are noted at the patient surfaces, Ϫ50% and ϩ20% at the anterior and posterior surfaces, respectively. As the patient moves posteriorly, the hot spot is found at the anterior surface. This surface dose effect has been previously described by Craig et al., 8 and occurs be- cause the dose convolution method represents a shifting of the dose distribution. Outside the patient, the dose is zero with the result that there is no dose to ''shift'' into the patient. 8 Note that the surface dose limitation of dose convolution was observed for the other patients in this study as well. Unlike in the work by Craig et al., 8 we have not modified the dose convolution method to correct for the surface dose irregularities. DVH's for the CTV and PTV for patient C were found to follow a different pattern compared to the other two patients: fluence convolution predicts more dose to both the CTV and PTV. One of the reasons for this is that the tumor motion occurs mostly in the anterior-posterior direction, which coincides with the direction of some of the beams used for the treatment plan. The decreased SSD in the fluence motion compensated plan leads to an increased dose to the PTV. This effect is not properly accounted for in the dose convolved plan where the dose is precalculated at the static SSD.
C. Beam edge vs inhomogeneity effects
In addition to hot/cold spots in the vicinity of the PTV, the dose difference maps in the previous analyses ͑Figs. 2, 4, 6-7͒ show differences along the beam edges. These differences are a result of the convolution of the static dose distribution which tends to blur out the beam penumbra causing an unsharp edge. In the case of fluence convolution, the dose distribution is also influenced by the local tissue densitiesthe dose distribution will be spatially variant in the presence of inhomogeneous tissues. To better understand the beam edge versus inhomogeneity effect on the motion convolved dose distributions we performed a calculation for patient B assuming that the CT densities were water equivalent ͑all values were set to 1.0͒. The idea was to isolate the beam edge differences from those due to the tissue inhomogeneities. Results of this analysis showed differences of up to ϩ23% due only to the beam edge effect of the fluence convolution. The combined dose difference map ͑fluence convolution-static͒ in the heterogeneous density case ͓shown earlier in Fig. 6͑a͔͒ includes both the beam edge and inhomogeneity effects and shows maximum differences of ϩ28%. The spatial variation of the dose distribution due to the inhomogeneity effect, for this particular plan, was on the order of 5%, which is consistent with the differences noted between fluence and dose convolution for this same case.
IV. CONCLUSION
In this study we account for some of the effects of breathing-induced target motion in the vicinity of the lung using convolution methods. Significant hot and cold spots (Ϯ15% -25%) were found in the dose difference maps between the motion convolved and static dose distributions as a result of the target motion. Smaller differences were observed between fluence and dose convolution-these differences are mainly due to the spatial invariance of the dose convolution distribution in the presence of the low density lung tissue. This investigation would not be complete without addressing the limitations of convolution methods in accounting for respiratory induced motion. Both fluence and dose convolution methods do not address the dose per fraction effects, which may potentially be important as recently demonstrated in a study by Craig et al. 9 In addition, dose convolution assumes shift invariance of the dose distribution, which is shown both here and in a recent study by Craig et al. 8 to have limitations. Finally, we have not included in this study an evaluation of the doses to the normal lung because convolution methods do not take into account the increase in volume of the lung with inhalation. The change in volume as well as the deformation of the normal lung tissue during respiration 2 must be correctly accounted for in order to accurately estimate the dose to the lung. Some work 19, 20 has begun in this area but further investigation is clearly warranted. 
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